| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $277,389 ) |
| | 2025 | 2025 | SYNVENTA LLC | 5117 N FAIRWAY HEIGHTS DR | TUCSON | AZ | 85749-7132 | PIMA | USA | R43DA061953 | Etimizol for reversal of Xylazine-fentanyl respiratory depression | 000 | 1 | NIH | 1/10/2025 | $277,389 |
|
| Issue Date FY: 2020 ( Subtotal = $0 ) |
| | 2020 | 2019 | SYNVENTA LLC | 5117 N FAIRWAY HEIGHTS DR | TUCSON | AZ | 85749-7132 | PIMA | USA | R43DA050395 | Fixed dose analgesic combination with non-opioid mechanism to prevent opioid misuse | 000 | 1 | NIH | 9/20/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $222,276 ) |
| | 2019 | 2019 | SYNVENTA LLC | 5117 N FAIRWAY HEIGHTS DR | TUCSON | AZ | 85749-7132 | PIMA | USA | R43DA050395 | Fixed dose analgesic combination with non-opioid mechanism to prevent opioid misuse | 000 | 1 | NIH | 9/16/2019 | $222,276 |
| | 2019 | 2019 | SYNVENTA LLC | 5117 N FAIRWAY HEIGHTS DR | TUCSON | AZ | 85749-7132 | PIMA | USA | R43DA050395 | Fixed dose analgesic combination with non-opioid mechanism to prevent opioid misuse | 001 | 1 | NIH | 9/17/2019 | $0 |
|
|
